UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9984, pp. 2288 - 2295
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Pyridines - administration & dosage | Double-Blind Method | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Pyridines - pharmacokinetics | Factor Xa Inhibitors - pharmacokinetics | Thiazoles - administration & dosage | Treatment Outcome | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Factor Xa Inhibitors - administration & dosage | Pyridines - adverse effects | Factor Xa Inhibitors - adverse effects | Hemorrhage - chemically induced | Clinical trials | Warfarin | Analysis | Atrial fibrillation | Anticoagulants | Cardiac arrhythmia | Stroke | Drug dosages | Medical treatment | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus | Life Sciences | Food and Nutrition | Animal biology | Cellular Biology | Pharmaceutical sciences | Cardiovascular Diseases | drug therapy | Benzhydryl Compounds | complications | Sodium-Glucose Transporter 2 Inhibitors | Hospitalization | prevention & control | Klinisk medicin | Diabetes Mellitus | etiology | Clinical Medicine | epidemiology | statistics & numerical data | adverse effects | mortality | Type 2 | Heart Failure | therapeutic use | Glucosides
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 10, pp. 1145 - 1154
Cardiovascular | Internal Medicine | coronary artery disease | P2Y12 receptor | aspirin | Key Words aspirin | receptor | P2Y | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - blood | Adenosine - pharmacokinetics | Purinergic P2Y Receptor Antagonists - administration & dosage | Follow-Up Studies | Humans | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Treatment Outcome | Adenosine - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - drug therapy | Time Factors | Adenosine - analogs & derivatives | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Prevention | Medical colleges | Aspirin | Hospitals | Cardiac patients | Research institutes | Cardiology | Heart diseases | Confidence intervals | Adenosine | Phosphorylation | Heart attacks | Blood platelets | Coronary vessels | Cardiovascular disease | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Atherosclerosis - drug therapy | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Incidence | Cardiovascular Diseases - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Least-Squares Analysis | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Drug Therapy, Combination | Prevention | Treatment outcome | Cardiovascular diseases | Drug therapy | Analysis | Stroke | Monoclonal antibodies | Cardiovascular disease | Patients | Drug dosages | Low density lipoprotein | Statins | Clinical outcomes | Cholesterol | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1591 - 1599
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Male | Secondary Prevention | Cyclopropanes - adverse effects | Protein Kinase Inhibitors - adverse effects | Cyclopropanes - therapeutic use | Pyridines - adverse effects | Treatment Failure | Female | C-Reactive Protein - analysis | Myocardial Infarction - enzymology | Pyridines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Myocardial Ischemia - prevention & control | Hospitalization | Myocardial Revascularization | Algorithms | Myocardial Infarction - drug therapy | Protein Kinase Inhibitors - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Aged | Myocardial Ischemia - surgery | Clinical trials | Care and treatment | Usage | Dosage and administration | Extracellular signal-regulated kinases | Heart attack | Patient safety | Inhibitor drugs | Heart attacks | Clinical outcomes | Index Medicus | Abridged Index Medicus | Pyridines/adverse effects/therapeutic use | Cyclopropanes/adverse effects/therapeutic use | C-Reactive Protein/analysis | Klinisk medicin | Clinical Medicine | p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors | Myocardial Ischemia/prevention & control/surgery | Protein Kinase Inhibitors/adverse effects/therapeutic use | Myocardial Infarction/drug therapy/enzymology/mortality
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2016, Volume 67, Issue 23, pp. 2719 - 2728
peripheral arterial disease | ticagrelor | major adverse cardiovascular events | major adverse limb events | acute limb ischemia | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - epidemiology | Purinergic P2Y Receptor Antagonists - administration & dosage | Vascular Grafting - statistics & numerical data | Humans | Middle Aged | Male | Secondary Prevention | Ischemia - prevention & control | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Purinergic P2Y Receptor Antagonists - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Lower Extremity - surgery | Drug Therapy, Combination | Stroke - prevention & control | Hemorrhage - epidemiology | Ischemia - epidemiology | Adenosine - administration & dosage | Peripheral Arterial Disease - epidemiology | Adenosine - analogs & derivatives | Ischemia - surgery | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Lower Extremity - blood supply | Prevention | Medical colleges | Care and treatment | Ischemia | Cardiology | Heart attack | Heart failure | Anticoagulants | Aspirin | Stroke | Heart attacks | Heart surgery | Mortality | Cardiovascular disease | Confidence intervals | Disease prevention | Coronary vessels | Amputation | Chronic obstructive pulmonary disease | Diabetes | Index Medicus | Abridged Index Medicus | Kardiologi | Cardiac and Cardiovascular Systems | acute limb ischemia; major adverse cardiovascular events; major adverse limb events; peripheral arterial disease; ticagrelor
Journal Article
7.
Full Text
Healthy-lifestyle behaviors associated with overweight and obesity in US rural children
BMC pediatrics, ISSN 1471-2431, 07/2012, Volume 12, Issue 1, pp. 102 - 102
Rural | Obesity | Diet | Physical activity | Vulnerable populations | Healthy lifestyle behaviors | Children | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Life Style | Prevalence | Cross-Sectional Studies | California - epidemiology | Humans | Mississippi - epidemiology | Logistic Models | Male | Health Behavior | Rural Health | Case-Control Studies | Exercise | South Carolina - epidemiology | Health Surveys | Overweight - epidemiology | Overweight - etiology | Obesity - epidemiology | Kentucky - epidemiology | Female | Obesity - etiology | Surveys and Questionnaires | Child | Government aid | Analysis | Obesity in children | Behavior | Beverages | Health aspects | Low income groups | Nutrition research | Statistical analysis | Nutrition | Families & family life | Rural schools | Population density | Manuscripts | Children & youth | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 05/2019, Volume 40, Issue 19, pp. 1541 - 1550
Journal Article